Lipoprotein Lipase (LPL) Peptide
LPL
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all Lipoprotein Lipase (LPL) products
- Lipoprotein Lipase (LPL)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LGYEINKVRA KRSSKMYLKT RSQMPYKVFH YQVKIHFSGT ESETHTNQAF
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LPL antibody,
Alternative Names: LPL control peptide, LPL antibody Blocking Peptide, Anti-LPL Blocking Peptide, lipoprotein lipase Blocking Peptide, HDLCQ11 Blocking Peptide, LIPD Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Lipoprotein Lipase (LPL)
- Background
- LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
- Molecular Weight
- 50 kDa
-
You are here:
